Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.

AVROBIO (AVRO) Stock Forecast & Price Target

AVROBIO logo
Get the Latest News and Ratings for AVRO and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for AVROBIO and its competitors.

Sign Up

AVRO Analyst Ratings Over Time

TypeCurrent Forecast
11/22/23 to 11/21/24
1 Month Ago
10/23/23 to 10/22/24
3 Months Ago
8/24/23 to 8/23/24
1 Year Ago
11/22/22 to 11/22/23
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
0 Buy rating(s)
0 Buy rating(s)
0 Buy rating(s)
2 Buy rating(s)
Hold
1 Hold rating(s)
1 Hold rating(s)
1 Hold rating(s)
1 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$24.00$24.00$24.00$48.00
Forecasted Upside1,614.29% Upside1,614.29% Upside1,614.29% Upside214.96% Upside
Consensus Rating
Hold
Hold
Hold
Moderate Buy
This Bull Market Indicator called NVDA at $116 (Ad)

Every now and again we find an investment idea so incredible we can’t help but share. And today is one of those rare days… Except, today we won't be giving you insight on any one particular stock… But rather, insight on a revolutionary new stock picking indicator… In fact, within the last year, this indicator has become famous for a multitude of reasons… But one of the biggest was because of the buy signal it issued on October 18th, 2022. In fact, on that very day, it said to buy NVDA at $116.37… Anyone who did would be sitting on a tremendously large return today… But even if you missed the original buy signal from October, this incredible indicator issued 11 other buy signals while Nvidia made its epic run…

All you have to do is follow this link here

AVRO Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

AVRO Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

AVROBIO Stock vs. The Competition

TypeAVROBIOMedical CompaniesS&P 500
Consensus Rating Score
2.00
2.80
2.50
Consensus RatingHoldModerate BuyModerate Buy
Predicted Upside1,614.29% Upside27,212.41% Upside8.86% Upside
News Sentiment Rating
Neutral News

See Recent AVRO News
Neutral News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
12/18/2023Mizuho
2 of 5 stars
 DowngradeBuy ➝ Neutral$60.00 ➝ $24.00+47.06%
7/13/2023Wells Fargo & Company
3 of 5 stars
 Lower Target$30.00 ➝ $24.00+39.86%
7/12/2023Wedbush
4 of 5 stars
D. Nierengarten
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeOutperform ➝ Neutral
3/24/2023Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingBuy$72.00+574.16%
12/7/2022BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeNeutral ➝ Buy$48.00+411.77%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Thursday at 12:22 PM ET.


AVRO Forecast - Frequently Asked Questions

According to the research reports of 1 Wall Street equities research analysts, the average twelve-month stock price forecast for AVROBIO is $24.00, with a high forecast of $24.00 and a low forecast of $24.00.

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for AVROBIO in the last year. There is currently 1 hold rating for the stock. The consensus among Wall Street analysts is that investors should "hold" AVRO shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in AVRO, but not buy additional shares or sell existing shares.

According to analysts, AVROBIO's stock has a predicted upside of 1,614.29% based on their 12-month stock forecasts.

Analysts like AVROBIO less than other "medical" companies. The consensus rating for AVROBIO is Hold while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how AVRO compares to other companies.


This page (NASDAQ:AVRO) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners